Figure 4

Comparative invivo pharmacokinetics of Dolutegravir and chitosan nanoparticles administered as milk admixture. (A) Plasma biodistribution of DTG after single oral administration. (B) Timewise plasma drug concentration of the Chitosan NPs compared with pure drug.